Terms: = Bone cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
439 results:
1. brd4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines.
Lang C; Stickler S; Rath B; Teufelsbauer M; Weigl L; Hohenegger M; Hamilton G
Anticancer Res; 2024 Mar; 44(3):971-980. PubMed ID: 38423674
[TBL] [Abstract] [Full Text] [Related]
2. Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.
Gnoli M; Gambarotti M; Righi A; Staals EL; Evangelista A; Tremosini M; Brizola E; Mordenti M; Boarini M; Locatelli M; Pedrini E; Sangiorgi L
Orphanet J Rare Dis; 2024 Feb; 19(1):63. PubMed ID: 38351015
[TBL] [Abstract] [Full Text] [Related]
3. Burden of comorbidities: Osteoporotic vertebral fracture during non-small cell lung cancer - the bone study.
Ebstein E; Brocard P; Soussi G; Khoury R; Forien M; Khalil A; Vauchier C; Juge PA; Léger B; Ottaviani S; Dieudé P; Zalcman G; Gounant V
Eur J Cancer; 2024 Mar; 200():113604. PubMed ID: 38340385
[TBL] [Abstract] [Full Text] [Related]
4. Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy.
Stanford SM; Nguyen TP; Chang J; Zhao Z; Hackman GL; Santelli E; Sanders CM; Katiki M; Dondossola E; Brauer BL; Diaz MA; Zhan Y; Ramsey SH; Watson PA; Sankaran B; Paindelli C; Parietti V; Mikos AG; Lodi A; Bagrodia A; Elliott A; McKay RR; Murali R; Tiziani S; Kettenbach AN; Bottini N
Sci Adv; 2024 Feb; 10(5):eadg7887. PubMed ID: 38295166
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological characteristics and prognostic factors of atypical meningiomas with bone invasion: a retrospective analysis of nine cases and literature review.
Cucu AI; Costea CF; Macovei G; Dumitrescu GF; Sava A; Blaj LA; Prutianu I; Porumb-Andrese E; Dascălu CG; Coşman M; Poeată I; Turliuc Ş
Rom J Morphol Embryol; 2023; 64(4):509-515. PubMed ID: 38184831
[TBL] [Abstract] [Full Text] [Related]
6. Engineering alginate-based injectable hydrogels combined with bioactive polymers for targeted plasma-derived oxidative stress delivery in osteosarcoma therapy.
Espona-Noguera A; Tampieri F; Canal C
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128841. PubMed ID: 38104678
[TBL] [Abstract] [Full Text] [Related]
7. Volumetric Analysis of Spheno-Orbital Meningiomas: Prognostic Correlation and a Compartmentalized Approach.
Zohdy YM; Jacob F; Agam M; Alawieh A; Bray D; Barbero JMR; Argaw SA; Maldonado J; Rodas A; Sudhakar V; Porto E; Peragallo JH; Olson JJ; Pradilla G; Garzon-Muvdi T
Neurosurgery; 2024 Apr; 94(4):736-744. PubMed ID: 37931131
[TBL] [Abstract] [Full Text] [Related]
8. A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.
Chen Z; Yang X; Chen Z; Li M; Wang W; Yang R; Wang Z; Ma Y; Xu Y; Ao S; Liang L; Cai C; Wang C; Deng T; Gu D; Zhou H; Zeng G
BMC Med; 2023 Oct; 21(1):402. PubMed ID: 37880708
[TBL] [Abstract] [Full Text] [Related]
9. Imaging of solitary and multiple osteochondromas: From head to toe - A review.
Pontes ÍCM; Leão RV; Lobo CFT; Paula VT; Yamachira VS; Baptista AM; Helito PVP
Clin Imaging; 2023 Nov; 103():109989. PubMed ID: 37778187
[TBL] [Abstract] [Full Text] [Related]
10. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract] [Full Text] [Related]
11. Magnetic Resonance Imaging Evaluation of Common Spinal Intramedullary Tumours: Ependymoma and Astrocytoma.
Sultana N; Jabeen S; Rima S; Nag UK; Sarkar SK
Mymensingh Med J; 2023 Jul; 32(3):749-756. PubMed ID: 37391969
[TBL] [Abstract] [Full Text] [Related]
12. Secondary Peripheral Dedifferentiated Chondrosarcoma: A Case Report with Special Emphasis on the Radiology/Pathology Correlation.
Yoshimoto M; Setsu N; Yokoyama N; Taguchi K; Kohashi K; Oda Y
JBJS Case Connect; 2023 Apr; 13(2):. PubMed ID: 37262190
[TBL] [Abstract] [Full Text] [Related]
13. Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment.
Xu P; Yang JC; Chen B; Nip C; Van Dyke JE; Zhang X; Chen HW; Evans CP; Murphy WJ; Liu C
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37147019
[TBL] [Abstract] [Full Text] [Related]
14. Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate cancer.
Sharma S; Mahajan SD; Chevli K; Schwartz SA; Aalinkeel R
Crit Rev Ther Drug Carrier Syst; 2023; 40(4):69-100. PubMed ID: 37075068
[TBL] [Abstract] [Full Text] [Related]
15. Thin Cartilage cap May Be Related to the Spontaneous Regression in Pediatric Patients with Osteochondroma.
Adachi R; Nakamura T; Asanuma K; Hagi T; Uchiyama T; Sudo A
Curr Oncol; 2022 Dec; 29(12):9884-9890. PubMed ID: 36547191
[TBL] [Abstract] [Full Text] [Related]
16. Rib osteochondroma presenting as acute paraparesis.
Kumar P; Badhe P; Dey AK
J Cancer Res Ther; 2022; 18(6):1807-1808. PubMed ID: 36412449
[TBL] [Abstract] [Full Text] [Related]
17. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer.
Mateu-Sanz M; Ginebra MP; Tornín J; Canal C
Free Radic Biol Med; 2022 Aug; 189():32-41. PubMed ID: 35843475
[TBL] [Abstract] [Full Text] [Related]
18. Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.
Ruchalski K; Kim HJ; Douek M; Raman S; Patel M; Sai V; Gutierrez A; Levine B; Fischer C; Allen-Auerbach M; Gupta P; Coy H; Villegas B; Brown M; Goldin J
Cancer Imaging; 2022 Jul; 22(1):34. PubMed ID: 35836271
[TBL] [Abstract] [Full Text] [Related]
19. A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro.
Cen W; Reinert S; Avci-Adali M; Alexander D; Umrath F
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786686
[TBL] [Abstract] [Full Text] [Related]
20. Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
Bhanvadia RR; Baky FJ; Ashbrook CQ; Lotan Y; Woldu SL
Urol Oncol; 2022 Aug; 40(8):384.e1-384.e8. PubMed ID: 35662499
[TBL] [Abstract] [Full Text] [Related]
[Next]
